JPRN-jRCTs031210365招募中2 期
JCOG2006: A randomized phase II study comparing preoperative adjuvant chemotherapy with mFOLFOX6 versus FOLFOXIRI for resectable locally advanced colon cancer - NAC-CC ranPII
TAKII Yasumasa0 个研究点目标入组 86 人开始时间: 2021年10月4日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 86
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 18age old 至 <= 75age old(—)
- 性别
- All
入选标准
- •(1) Pathologically proven colorectal adenocarcinoma with endoscopic biopsy specimen.
- •(2) Tumor is mainly located between cecum and rectal sigmoid colon.
- •(3) Diagnosed on contrast-enhanced abdominal/pelvic CT(<=1.25mm) either (a) or (b)
- •(a) cT4b and cN+
- •(b) cT3-T4a and cN2-3
- •(4) No distant metastasis on chest CT and contrast-enhanced abdominal/pelvic CT (cM0).
- •(5) Age, 18 - 75 years old.
- •(6) ECOG Performance status, 0 or 1.
- •(7) No prior chemotherapy.
- •(8) No multiple colorectal cancer diagnosed on colonscopy and imaging test.
- •(9) UGT1A1 genotypes that do not include *6/*6, *28/*28, or *6/*28.
- •(10) Sufficient organ function.
- •(a) Neutrophil count >= 1,500 /mm3
- •(b) Hemoglobin >= 8.0 mg/dL
- •(c) Platelet count >= 100,000 /mm3
- •(d) AST =< 100 U/L
- •(e) ALT =< 100 U/L
- •(f) Total Bilirubin =< 2.0 mg/dL
- •(g) Cr =< 1.5 mg/dL
- •(11) Without ileus or bowel perforation.
- •(12) Written informed consent is obtained.
排除标准
- •(1) Synchronous or metachronous (within 5 years) malignancies
- •(2) Infections which needs systemic treatment.
- •(3) Body temperature is higher than 38 degrees centigrade at registration.
- •(4) Female during pregnancy, within 28 days of postparturition, or during lactation. Male who wants partner's pregnancy.
- •(5) Severe psychological disease.
- •(6) Continuous systemic corticosteroid or immunosuppressant treatment.
- •(7) Uncontrollable diabetes mellitus.
- •(8) Uncontrollable hypertension.
- •(9) Unstable angina pectoris, or history of myocardial infarction within 6 months.
- •(10) Uncontrollable valvular heart disease, dilated cardiomyopathy, or hypertrophic cardiomyopathy.
- •(11) Regularly using phenytoin.
- •(12) Interstitial pneumonia, pulmonary fibrosis, severe emphysema diagnosed on chest CT.
研究者
相似试验
招募中
2 期
JCOG2204: A randomized phase II study to compare the pathological responses of neoadjuvant chemotherapy for type 4 or large type 3 gastric cancer: 5-FU, Oxaliplatin and Docetaxel (FLOT) versus Docetaxel, Oxaliplatin and S-1 (DOS)Resectable large type 3 or type 4 gastric cancerJPRN-jRCTs031230231OHASHI Manabu76
已完成
2 期
JCOG1207: A randomized controlled phase II/III study comparing EBD combined with steroid versus RIC combined with steroid for refractory anastomotic stricture after esophagectomyRefractory anastomotic stricture after surgical resection for esophageal cancerJPRN-jRCTs031180177MUTO Manabu130
招募中
3 期
JCOG2206: A randomized controlled phase III study comparing surgery alone versus adjuvant nivolumab versus adjuvant S-1 for locally advanced esophageal squamous cell carcinoma with no pathological complete response after neoadjuvant chemotherapy followed by curative esophagectomyEsophageal squamous cell carcinoma with no pathological complete response after neoadjuvant therapyJPRN-jRCTs031230219KITAGAWA Yuko450
进行中(未招募)
不适用
Randomized Phase II AGO-Study comparing combined liposomal doxorubicin (Myocet) and gemcitabine (Gemzar) with liposomal doxorubicin (Myocet) monotherapy in platinum-refractory and platinum-resistant epithelial cancer of the ovary, fallopian tube, and the peritoneum - AGO 10EUCTR2008-008746-20-ATStudienzentrale AGO Austria154
招募中
3 期
JCOG1701: Randomized phase III study comparing cessation or continuation of PD-1 Pathway Blockade for patients with advanced non-small-cell lung cancerJPRN-jRCT1031190032OHE Yuichiro172
